These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7853793)

  • 1. Contribution of renal angiotensin II type I receptor to gene expressions in hypertension-induced renal injury.
    Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Wada T; Ishimura Y; Chatani F
    Kidney Int; 1994 Nov; 46(5):1346-58. PubMed ID: 7853793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats.
    Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Ishimura Y; Chatani F; Iwao H
    J Pharmacol Exp Ther; 1995 Apr; 273(1):509-15. PubMed ID: 7714806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal protective effect of TCV-116 in stroke-prone spontaneously hypertensive rats.
    Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Wada T; Ishimura Y; Chatani F
    Blood Press Suppl; 1994; 5():54-6. PubMed ID: 7889201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of angiotensin II in renal injury of deoxycorticosterone acetate-salt hypertensive rats.
    Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Wada T; Ishimura Y; Chatani F
    Hypertension; 1994 Aug; 24(2):195-204. PubMed ID: 8039844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of angiotensin II in cardiovascular and renal injury: effects of an AT1-receptor antagonist on gene expression and the cellular phenotype.
    Kim S; Iwao H
    J Hypertens Suppl; 1997 Dec; 15(6):S3-7. PubMed ID: 9493120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased gene expression of components of the renin-angiotensin system in glomeruli of genetically hypertensive rats.
    Obata J; Nakamura T; Takano H; Naito A; Kimura H; Yoshida Y; Shimizu F; Guo DF; Inagami T
    J Hypertens; 2000 Sep; 18(9):1247-55. PubMed ID: 10994756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of vascular transforming growth factor-beta1 and extracellular matrix gene expressions by cilazapril and nifedipine in hypertensive rats.
    Kim S; Ohta K; Hamaguchi A; Miura K; Yukimura T; Iwao H
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S355-6. PubMed ID: 9072426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats.
    Inada Y; Wada T; Ojima M; Sanada T; Shibouta Y; Kanagawa R; Ishimura Y; Fujisawa Y; Nishikawa K
    Clin Exp Hypertens; 1997 Oct; 19(7):1079-99. PubMed ID: 9310205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of an AT1 receptor antagonist, an ACE inhibitor and a calcium channel antagonist on cardiac gene expressions in hypertensive rats.
    Kim S; Ohta K; Hamaguchi A; Yukimura T; Miura K; Iwao H
    Br J Pharmacol; 1996 Jun; 118(3):549-56. PubMed ID: 8762077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of AT1 receptor antagonist on proteoglycan gene expression in hypertensive rats.
    Sasamura H; Shimizu-Hirota R; Nakaya H; Saruta T
    Hypertens Res; 2001 Mar; 24(2):165-72. PubMed ID: 11325076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candesartan prevents the progression of glomerulosclerosis in genetic hypertensive rats.
    Obata J; Nakamura T; Kuroyanagi R; Yoshida Y; Guo DF; Inagami T
    Kidney Int Suppl; 1997 Dec; 63():S229-31. PubMed ID: 9407467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of angiotensin II in cerebrovascular and renal damage in deoxycorticosterone acetate-salt hypertensive rats.
    Wada T; Kanagawa R; Ishimura Y; Inada Y; Nishikawa K
    J Hypertens; 1995 Jan; 13(1):113-22. PubMed ID: 7759841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal responses to angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor in partially nephrectomized spontaneously hypertensive rats.
    Okada H; Suzuki H; Kanno Y; Ikenaga H; Saruta T
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):564-9. PubMed ID: 8569216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II type 1 receptor blockade inhibits the expression of immediate-early genes and fibronectin in rat injured artery.
    Kim S; Kawamura M; Wanibuchi H; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Iwao H
    Circulation; 1995 Jul; 92(1):88-95. PubMed ID: 7788922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional hemodynamic effects of candesartan cilexetil (TCV-116), an angiotensin II AT1-receptor antagonist, in conscious spontaneously hypertensive rats.
    Kanagawa R; Wada T; Sanada T; Ojima M; Inada Y
    Jpn J Pharmacol; 1997 Mar; 73(3):185-90. PubMed ID: 9127812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of angiotensin II type 1 receptor in the leucocytes and endothelial cells of brain microvessels in the pathogenesis of hypertensive cerebral injury.
    Ito H; Takemori K; Suzuki T
    J Hypertens; 2001 Mar; 19(3 Pt 2):591-7. PubMed ID: 11327634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor beta 1 and extracellular matrix gene expression in isoprenaline induced cardiac hypertrophy: effects of inhibition of the renin-angiotensin system.
    Omura T; Kim S; Takeuchi K; Iwao H; Takeda T
    Cardiovasc Res; 1994 Dec; 28(12):1835-42. PubMed ID: 7867037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta 1 expression and phenotypic modulation in the kidney of hypertensive rats.
    Hamaguchi A; Kim S; Ohta K; Yagi K; Yukimura T; Miura K; Fukuda T; Iwao H
    Hypertension; 1995 Jul; 26(1):199-207. PubMed ID: 7541781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of candesartan cilexetil (TCV-116) and enalapril in 5/6 nephrectomized rats.
    Noda M; Fukuda R; Matsuo T; Ohta M; Nagano H; Imura Y; Nishikawa K; Shibouta Y
    Kidney Int Suppl; 1997 Dec; 63():S136-9. PubMed ID: 9407442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin AT1 receptor antagonism and protection against cardiovascular end-organ damage.
    Nishikawa K
    J Hum Hypertens; 1998 May; 12(5):301-9. PubMed ID: 9655651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.